4//SEC Filing
Ali Faraz 4
Accession 0000950170-25-036770
CIK 0001858848other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 9:42 PM ET
Size
7.4 KB
Accession
0000950170-25-036770
Insider Transaction Report
Form 4
Ali Faraz
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-03-10$0.54/sh−3,947$2,125→ 320,514 total - Sale
Common Stock
2025-03-10$0.54/sh−5,794$3,119→ 324,461 total
Footnotes (5)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
- [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Includes 278,799 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F4]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
- [F5]Includes 268,174 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Documents
Issuer
Tenaya Therapeutics, Inc.
CIK 0001858848
Entity typeother
Related Parties
1- filerCIK 0001667937
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 9:42 PM ET
- Size
- 7.4 KB